We aren’t talking about penny stocks we are talking about a tech giant. At the scales that any ordinary investor is operating at there will be no liquidity issues with shorting it and if it is in your index fund the short and long positions will directly offset if you size it correctly leading you to have net zero exposure to SpaceX.
They're saying if the stock goes up and you get margin-called on the short, you have to sell index shares, you can't just annihilate the Tesla shares with the anti-Tesla shares and walk away.
I think most people trade synthetic, just because it's faster and you don't have to wait for settlements, but maybe that is different if you trade onshore (I am a foreign investor).
Anyway if you are synthetic your margin is most likely shared between shorts and long on the same instrument, so no, you wouldn't be called.
Yeah you're not wrong. I didn't think about it that way because you can't really break something out of an ETF basket, and you also don't control the ETF basket, but if you think those risks are minimal it's probably fine to just compare dollars-to-dollars.
Personally I would still probably go with the long put strategy unless the price difference is exorbitant.
The ETF that seemingly arbitrarily changes its rules? In such a short time frame too? This change is going proposal to implementation in.. what, two weeks total? I don't know about you but I don't keep up on this stuff unless it hits the news like this one.
You are not entering a contract with a long put. You are buying a contract that, if you want, you can just let expire with no obligation to do anything. It's effectively simple insurance (as opposed to a short position, which is an actual liability, which will eat you alive in exceptional circumstances).
Yes you are, and options are complicated. Actually, the mere fact that you think they are "simple insurance" is enough proof to me that you probably don't understand it enough to safely buy one.
> You are buying a contract
Oh right, you've bought a PUT, now the fun part: you have to manage your position/exposure, could you enlighten me how you do that?
Could you explain me why buying a SpaceX PUT in a high IV regime (e.g. soon after IPO) will have it drop 40% when the IV decreases after 1 month, even though price moved in my favor? It should be simple, it's just a simple insurance product right?
Seriously. Someone, likely not super financially literate, ask a simple question about how to neutralize a stock exposure, and your answer is to advise buying options? Just stop.
Look, I think you're missing my point a little bit. Let's simplify it to risk, since that's what kicked off this conversation.
Your pension or whatever holds an ETF that (soon) contains some SpaceX shares. You buy a put option on SpaceX direct. What's the absolute worst thing that could happen?
Your pension or whatever holds an ETF that (soon) contains some SpaceX shares. You short sell a SpaceX share. What's the absolute worst thing that could happen?
Because they're doing the fancy equivalent of selling $20 bills for $15 and chirping about how high their revenue is. You, me, and everyone else could generate $inf revenue with that strategy, but that doesn't make it a viable business model.
I have no doubt there are a handful of positive examples when we ignore the tens of thousands of failed companies along these lines.
I have no problem with money-furnaces trading publicly. If people want to invest in those, fantastic, power to them. But they absolutely should not be included in vehicles like pensions and indexes.
We don't know which of today's companies will be successful and/or highly-valued in N years' time.
Check Cisco's valuation on March 27, 2000; it was briefly the most valuable publically traded company in the world. Almost everyone believed it was worth it. Then it fell 88% over two years.
Full disclosure: some of us are old enough to have held stocks during the dot-com boom. Fortunately I was still a student and therefore too poor to have had any significant amount of money to lose :)
Interestingly, these are the exact rules they're working to overturn: currently, no matter how many stupid accounting tricks you pull off, you need to actually be profitable to be included in the S&P 500.
For the same reason it doesn't happen with humans.
Even for AI, it's probably better off paying another AI that is specializing in something and done all the work rather then reimplementing everything from the ground up.
Is it specializing though? If both you and them have built your business on the latest Opus.. where is the specialization?
"From the ground up" used to be a moat, but if the LLM marketing materials are to be believed, Joe Lunchbox can slop-code a 95%-equivalent of any SaaS over a weekend with a $100 subscription.. so why would it ever make sense for a business to pay a non-trivial recurring expense for something they can do themselves?
I'm not an accountant, but afaik run rate is not a GAAP recognized metric. Presumably investors who care want it to be more precisely defined. In practice usually I've seen it be extrapolating the previous month. E.g. if you have per month revenue, that's what you want to extrapolate - I've only really seen run rate with SaaS where you have recurring revenue.
Occasionally it can be a snapshot if you've just completed a big contract - but it's what you expect to get per month if you're not growing or shrinking for the typical SaaS that charges per month (and assuming yearly pre-paid contracts renew etc.)
Collecting invoices is cash accounting, whereas revenue is realized only over the length of the contract and doesn’t care when the customer pays. (Of course sometimes you have a short-term contract including for professional services and such, but not to the point where a single day would likely be particularly inflated.)
For Anthropic in particular, that we're talking about, API token costs are revenue that is earned in real-time not on a contract - so hypothetically a giant spike in token use on an API use contract could spike revenue. But I don't think most expect that to randomly fluctuate enough to be material.
Are you trying to be deliberately obtuse? Obviously, you can fudge the number with assumptions around churn rates/etc, but of course an investor would want a view of the rough 12m state of the business.
...which is why we have GAAP-recognized metrics, right? To prevent fudge-ability? And those metrics.. they're deliberately not publishing? Makes you think.
GAAP is basically a standards body to recognize practices.
When there are interesting stories that can't be told with GAAP metrics, accountants derive new metrics. Just because they haven't gone through the standardization process yet doesn't mean they're bullshit - investors in Anthropic can hire auditors to ensure the Anthropic metrics are still meaningful. There are a very small number of deep pocketed investors in Anthropic - they're not a public company like Enron trying to sell to the WSB crowd, or like 2007 CDOs being sold to dentists.
And run rate has been a widely recognized metric for SaaS as long as it has existed - it has meaning and can be audited.
reply